Research Industries
This article was originally published in The Gray Sheet
Executive Summary
Begins marketing the VisuFlo surgical site visualization wand the week of Feb. 8; the product was cleared by FDA via 510(k) on Feb. 5. VisuFlo employs a stream of moistened air to clear blood from a surgical site, thereby improving visualization. Research Industries' first blood field management product, the Sof-Touch external blood vessel occluder, was cleared in May 1992 ("The Gray Sheet" June 1, In Brief). Two additional occlusion devices, the Sure-Fit NormoCluder and VascuCluder, received 510(k) clearances in January.
|
Begins marketing the VisuFlo surgical site visualization wand the
week of Feb. 8; the product was cleared by FDA via 510(k) on Feb.
5. VisuFlo employs a stream of moistened air to clear blood from a
surgical site, thereby improving visualization. Research
Industries' first blood field management product, the Sof-Touch
external blood vessel occluder, was cleared in May 1992 ("The Gray
Sheet" June 1, In Brief). Two additional occlusion devices, the
Sure-Fit NormoCluder and VascuCluder, received 510(k) clearances in
January. |